Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous N-acetylcysteine for prevention of renal impairment after cardiac surgery
ACTRN12606000088549Phase 3Recruiting
- Sponsor
- Prince of Wales Hospital
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acute kidney failure (AKF) comparing Intravenous N-acetylcysteine with Placebo (2 arms). Primary endpoint: Occurrence of acute renal failure. Started Aug 2004; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ACTRN12606000088549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000088549.